Patent · US Active

Methods and devices to induce controlled atelectasis and hypoxic pulmonary vasoconstriction

US8136526B2 · kind B2 · utility

18Cited by
10References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2007
Grant dateMar 20, 2012
Priority date
Expiry dateApr 28, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2002/068
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Lung conditions are treated by implanting a flow restrictor in a passageway upstream from a diseased lung segment. The restrictor will create an orifice at the implantation site which inhibits air exchange with the segment to induce controlled atelectasis and/or hypoxia. Controlled atelectasis can induce collapse of the diseased segment with a reduced risk of pneumothorax. Hypoxia can promote gas exchange with non-isolated, healthy regions of the lung even in the absence of lung collapse.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.